EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Histone modifications: Key players in Alzheimer's disease

Kun Li, Xiaolin Qiu, Qiqi Yang, Ziqiang Wang

Mechanisms of Ageing and Development · 2025-12 · 228 · 112102

DOI: 10.1016/j.mad.2025.112102 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mechanisms of Ageing and Development, 2025-12. Verfasst von Kun Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan 2…. Hauptthemen laut MEDLINE: Alzheimer Disease, Histones, Histone Code. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is one of the most prevalent diseases in the older population. AD causes progressive cognitive and behavioral impairment, but current treatments are unable to slow or prevent the progression of this disease. Thus, identification of novel biomarkers and therapeutic targets is urgently needed. We previously described the roles of histone acetylation, crotonylation, and lactylation in the accumulation of amyloid beta and hyperphosphorylation of Tau protein, which are the hallmarks of AD. In this review, we summarize and discuss the current knowledge of the role of histone modifications in AD, with a particular emphasis on its association with characterized pathological alterations, including amyloid plaques, Tau tangles, neuroinflammation, and synaptic dysfunction. This review provides novel insights into the central role of histone modifications in AD pathogenesis and evaluates histone-modifying enzymes as potential therapeutic targets for the treatment of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHistonesHistone CodeHumansAnimalstau ProteinsAmyloid beta-PeptidesAcetylation

Stichwörter der Autor:innen

Alzheimer's diseaseAβ plaqueshistone modifications

Substanzen

Histonestau ProteinsAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan 250014, China.
  • Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250062, China.
  • Department of Nuclear Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan 250014, China; Biomedical Sciences College & Shandong Medicinal Biotech…

Förderung

  • Shandong Province Natural Science Foundation

Zitieren

APA

Li, K., Qiu, X., Yang, Q., & Wang, Z. (2025). Histone modifications: Key players in Alzheimer's disease. Mechanisms of Ageing and Development, 228, 112102. https://doi.org/10.1016/j.mad.2025.112102

Vancouver

Li K, Qiu X, Yang Q, Wang Z. Histone modifications: Key players in Alzheimer's disease. Mechanisms of Ageing and Development. 2025;228:112102. doi:10.1016/j.mad.2025.112102

BibTeX
@article{Li2025,
  author = {Li, Kun and Qiu, Xiaolin and Yang, Qiqi and Wang, Ziqiang},
  title = {Histone modifications: Key players in Alzheimer's disease},
  journal = {Mechanisms of Ageing and Development},
  year = {2025},
  volume = {228},
  pages = {112102},
  doi = {10.1016/j.mad.2025.112102}
}
Kostenlos starten →